login
login

Europe Daily Bulletin No. 12715

8 May 2021
EU RESPONSE TO COVID-19 / Health
European Medicines Agency begins rolling review of a fourth potential treatment for Covid-19
Brussels, 07/05/2021 (Agence Europe)

On Friday 7 May, the European Medicines Agency (EMA) announced that it had started a rolling review of a new treatment for Covid-19.Sotrovimab is a monoclonal antibody treatment also known as VIR-7831 and GSK4182136, which was developed by the British pharmaceutical giant GSK and the American company Vir Biotechnology Inc.

This decision was based on preliminary results of a study on the drug’s ability to prevent hospitalisation or death in non-hospitalised patients with the virus, the...

Contents

PORTO SUMMIT
INSTITUTIONAL
EU RESPONSE TO COVID-19
ECONOMY - FINANCE - BUSINESS
EXTERNAL ACTION
SECTORAL POLICIES
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
COUNCIL OF EUROPE
NEWS BRIEFS
CALENDAR
CALENDAR EXTRA